These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 20852967)

  • 21. Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner.
    Zhao Z; de Beer MC; Cai L; Asmis R; de Beer FC; de Villiers WJ; van der Westhuyzen DR
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):168-73. PubMed ID: 15514202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients.
    Puccetti L; Sawamura T; Pasqui AL; Pastorelli M; Auteri A; Bruni F
    Eur J Clin Invest; 2005 Jan; 35(1):47-51. PubMed ID: 15638819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperlipidemia and type I 5'-monodeiodinase activity: regulation by selenium supplementation in rabbits.
    Kang BP; Bansal MP; Mehta U
    Biol Trace Elem Res; 2000 Dec; 77(3):231-9. PubMed ID: 11204465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silencing of either SR-A or CD36 reduces atherosclerosis in hyperlipidaemic mice and reveals reciprocal upregulation of these receptors.
    Mäkinen PI; Lappalainen JP; Heinonen SE; Leppänen P; Lähteenvuo MT; Aarnio JV; Heikkilä J; Turunen MP; Ylä-Herttuala S
    Cardiovasc Res; 2010 Dec; 88(3):530-8. PubMed ID: 20634212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of rutin on polymorphonuclear leukocytes oxidative metabolism in hypercholesterolemic Golden Syrian hamsters: evaluation by chemiluminescence and flow cytometry.
    Kanashiro A; Kabeya LM; Martinello F; Turato WM; Paula FS; Polizello AC; Uyemura SA; Lucisano-Valim YM
    Pharmazie; 2007 Apr; 62(4):295-8. PubMed ID: 17484287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress.
    Osto E; Matter CM; Kouroedov A; Malinski T; Bachschmid M; Camici GG; Kilic U; Stallmach T; Boren J; Iliceto S; Lüscher TF; Cosentino F
    Circulation; 2008 Nov; 118(20):2073-80. PubMed ID: 18955669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of dietary flavonoid quercetin against lipemic-oxidative hepatic injury in hypercholesterolemic rats.
    Mariee AD; Abd-Allah GM; El-Beshbishy HA
    Pharm Biol; 2012 Aug; 50(8):1019-25. PubMed ID: 22775419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuation of atherosclerotic complications by modulating inflammatory responses in hypercholesterolemic rats with dietary Njavara rice bran oil.
    Pushpan CK; V S; G S; Rathnam P; A J; A H
    Biomed Pharmacother; 2016 Oct; 83():1387-1397. PubMed ID: 27583979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrotic syndrome causes upregulation of HDL endocytic receptor and PDZK-1-dependent downregulation of HDL docking receptor.
    Vaziri ND; Gollapudi P; Han S; Farahmand G; Yuan J; Rahimi A; Moradi H
    Nephrol Dial Transplant; 2011 Oct; 26(10):3118-23. PubMed ID: 21459782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of serum lipid abnormalities and cardiac oxidative stress by eicosapentaenoate-lipoate (EPA-LA) derivative in experimental hypercholesterolemia.
    Kumar SA; Sudhahar V; Varalakshmi P
    Clin Chim Acta; 2005 May; 355(1-2):197-204. PubMed ID: 15820496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluvastatin prevents renal injury and expression of lactin-like oxidized low-density lipoprotein receptor-1 in rabbits with hypercholesterolemia.
    Yu YH; Wang Y; Dong B; Sun SZ; Chen Y; Meng XH; Liu ZZ
    Chin Med J (Engl); 2005 Apr; 118(8):621-6. PubMed ID: 15899115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of pattern recognition receptors in the induction of cytokines and reactive oxygen intermediates production by human monocytes/macrophages stimulated with tumour cells.
    Mytar B; Woloszyn M; Macura-Biegun A; Hajto B; Ruggiero I; Piekarska B; Zembala M
    Anticancer Res; 2004; 24(4):2287-93. PubMed ID: 15330174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of vitamin E and selenium on the renal morphology in rats fed high-cholesterol diets.
    Gonca S; Ceylan S; Yardimoğlu M; Dalçik H; Yumbul Z; Köktürk S; Filiz S
    Pathobiology; 2000; 68(6):258-63. PubMed ID: 11493758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathological changes due to the effect of selenium in experimental cockerels.
    Latheef SA; Radhika K; Subramanyam G
    Indian J Med Res; 2014 Jun; 139(6):927-32. PubMed ID: 25109728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corrigendum to "Diosgenin alleviates hypercholesterolemia via SRB1/CES-1/CYP7A1/FXR pathway in high-fat diet-fed rats" Toxicology and Applied Pharmacology, volume 412C (2021).
    Yu L; Lu H; Yang X; Li R; Shi J; Yu Y; Ma C; Sun F; Zhang S; Zhang F
    Toxicol Appl Pharmacol; 2021 Mar; 414():115423. PubMed ID: 33508267
    [No Abstract]   [Full Text] [Related]  

  • 36. Assessing the Efficacy of Dietary Selenomethionine Supplementation in the Setting of Cardiac Ischemia/Reperfusion Injury.
    Reyes L; Bishop DP; Hawkins CL; Rayner BS
    Antioxidants (Basel); 2019 Nov; 8(11):. PubMed ID: 31766199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on scavenger receptors under experimental hypercholesterolemia: modulation on selenium supplementation.
    Kaur H; Bansal MP
    Biol Trace Elem Res; 2011 Oct; 143(1):310-9. PubMed ID: 20852967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on HDL associated enzymes under experimental hypercholesterolemia: possible modulation on selenium supplementation.
    Kaur HD; Bansal MP
    Lipids Health Dis; 2009 Dec; 8():55. PubMed ID: 20015371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypercholesterolemia and LDL receptor mRNA expression: modulation by selenium supplementation.
    Dhingra S; Bansal MP
    Biometals; 2006 Oct; 19(5):493-501. PubMed ID: 16937255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of hypercholesterolemia-induced alterations in apolipoprotein B and HMG-CoA reductase expression by selenium supplementation.
    Dhingra S; Bansal MP
    Chem Biol Interact; 2006 May; 161(1):49-56. PubMed ID: 16581047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.